Summary
Market Segment as follows:
By Type
HM-15211
LBT-6030
LY-3298176
NNC-92041706
Others
By Application
Metabolic Disorder
Type 2 Diabetes
Obesity
Others
By Company
Alchemia Limited
AstraZeneca Plc
Carmot Therapeutics, Inc.
Diabetica Limited
Longevity Biotech, Inc
Novo Nordisk A/S
Sanofi
Zealand Pharma A/S
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Interested in this report?
Get your sample now!
Table of Content
1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 HM-15211
1.1.2.2 LBT-6030
1.1.2.3 LY-3298176
1.1.2.4 NNC-92041706
1.1.2.5 Others
1.1.3 Market by Application
1.1.3.1 Metabolic Disorder
1.1.3.2 Type 2 Diabetes
1.1.3.3 Obesity
1.1.3.4 Others
1.2 Global and China Market Size
1.2.1 Global Overview
1.2.2 China Overview
2 Global and China Market by Company
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 China
2.2.1 China Sales by Company
2.2.2 China Price by Company
3 Global and China Market by Type
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 China
3.2.1 China Sales by Type
3.2.2 China Price by Type
4 Global and China Market by Application
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 China
4.2.1 China Sales by Application
4.2.2 China Price by Application
5 China Trade
5.1 Export
5.2 Import
6 Key Manufacturers
6.1 Alchemia Limited
6.1.1 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 AstraZeneca Plc
6.3 Carmot Therapeutics, Inc.
6.4 Diabetica Limited
6.5 Longevity Biotech, Inc
6.6 Novo Nordisk A/S
6.7 Sanofi
6.8 Zealand Pharma A/S
7 Industry Upstream
7.1 Industry Chain
7.2 Raw Materials
8 Market Environment
8.1 SWOT
8.2 Porter's Five Forces
9 Conclusion
Figure HM-15211 Market Size and CAGR 2013-2018 (Million USD)
Figure HM-15211 Market Size and CAGR 2013-2018 (Volume)
Figure HM-15211 Market Forecast and CAGR 2019-2025 (Million USD)
Figure HM-15211 Market Forecast and CAGR 2019-2025 (Volume)
Figure LBT-6030 Market Size and CAGR 2013-2018 (Million USD)
Figure LBT-6030 Market Size and CAGR 2013-2018 (Volume)
Figure LBT-6030 Market Forecast and CAGR 2019-2025 (Million USD)
Figure LBT-6030 Market Forecast and CAGR 2019-2025 (Volume)
Figure LY-3298176 Market Size and CAGR 2013-2018 (Million USD)
Figure LY-3298176 Market Size and CAGR 2013-2018 (Volume)
Figure LY-3298176 Market Forecast and CAGR 2019-2025 (Million USD)
Figure LY-3298176 Market Forecast and CAGR 2019-2025 (Volume)
Figure NNC-92041706 Market Size and CAGR 2013-2018 (Million USD)
Figure NNC-92041706 Market Size and CAGR 2013-2018 (Volume)
Figure NNC-92041706 Market Forecast and CAGR 2019-2025 (Million USD)
Figure NNC-92041706 Market Forecast and CAGR 2019-2025 (Volume)
Figure Others Market Size and CAGR 2013-2018 (Million USD)
Figure Others Market Size and CAGR 2013-2018 (Volume)
Figure Others Market Forecast and CAGR 2019-2025 (Million USD)
Figure Others Market Forecast and CAGR 2019-2025 (Volume)
Figure Metabolic Disorder Market Size and CAGR 2013-2018 (Million USD)
Figure Metabolic Disorder Market Size and CAGR 2013-2018 (Volume)
Figure Metabolic Disorder Market Forecast and CAGR 2019-2025 (Million USD)
Figure Metabolic Disorder Market Forecast and CAGR 2019-2025 (Volume)
Figure Type 2 Diabetes Market Size and CAGR 2013-2018 (Million USD)
Figure Type 2 Diabetes Market Size and CAGR 2013-2018 (Volume)
Figure Type 2 Diabetes Market Forecast and CAGR 2019-2025 (Million USD)
Figure Type 2 Diabetes Market Forecast and CAGR 2019-2025 (Volume)
Figure Obesity Market Size and CAGR 2013-2018 (Million USD)
Figure Obesity Market Size and CAGR 2013-2018 (Volume)
Figure Obesity Market Forecast and CAGR 2019-2025 (Million USD)
Figure Obesity Market Forecast and CAGR 2019-2025 (Volume)
Figure Others Market Size and CAGR 2013-2018 (Million USD)
Figure Others Market Size and CAGR 2013-2018 (Volume)
Figure Others Market Forecast and CAGR 2019-2025 (Million USD)
Figure Others Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Gastric Inhibitory Polypeptide Receptor Market Size and CAGR 2013-2017 (Million USD)
Figure Global Gastric Inhibitory Polypeptide Receptor Market Size and CAGR 2013-2017 (Volume)
Figure Global Gastric Inhibitory Polypeptide Receptor Market Forecast and CAGR 2019-2025 (Million USD)
Figure Global Gastric Inhibitory Polypeptide Receptor Market Forecast and CAGR 2019-2025 (Volume)
Figure China Gastric Inhibitory Polypeptide Receptor Market Size and CAGR 2013-2017 (Million USD)
Figure China Gastric Inhibitory Polypeptide Receptor Market Size and CAGR 2013-2017 (Volume)
Figure China Gastric Inhibitory Polypeptide Receptor Market Forecast and CAGR 2019-2025 (Million USD)
Figure China Gastric Inhibitory Polypeptide Receptor Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure China Market Sales Revenue Share by Company in 2017
Figure China Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure China Market Sales Revenue Share by Type in 2017
Figure China Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure China Market Sales Revenue Share by Application in 2017
Figure China Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Gastric Inhibitory Polypeptide Receptor SWOT List
Figure Gastric Inhibitory Polypeptide Receptor Porter's Five Forces
